Adoption of a D&M digital thread and software-defined manufacturing will help Haddy further scale local production and use of ...

Global High Potency API CDMOs Market OverviewThe global high potency active pharmaceutical ingredient (HPAPI) CDMOs market is ...

Track Auro Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit ...

Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...

The article introduces an autonomous, AI-driven continuous manufacturing demonstrator that has been developed by the PIPAc consortium (Bruker, Novalix, Alysophil, and De Dietrich Process Systems). It ...

Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 ...

As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...

Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

Oil industry executives have voiced that reviving Venezuela's oil production will be a long and costly process. Companies will need stable, legally defined frameworks, security for investments, and ...

Inke is a manufacturer of inhalation active pharmaceutical ingredients Inke is based in Barcelona, Spain Pharmanoid’s products are authorized for commercialization in more than 25 countries Inke, ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...